GET IN TOUCH
Founded in 2013, Syntimmune is the world’s leader in the biology of the neonatal Fc receptor (FcRn). Helmed by the most recognized experts in its field, Syntimmune is positioned to rapidly advance breakthrough therapies which co-opt this unique target.
275 Grove Street, Building 2
Newton, MA 02466
257 Park Avenue South, 15th Floor
New York, NY 10010